Health Pfizer Beats Q3 Estimates and Raises 2026 Outlook Despite COVID Revenue Decline November 3, 2026 Pfizer delivered better-than-expected third-quarter results on Tuesday, prompting the pharmaceutical giant to raise its full-year 2026 outlook even as demand for its COVID-19 products continues to wane. The company reported…